RLMD Stock: Relmada Therapeutics, Inc. Stock Price, Analysis & Insights
Get live rlmd stock price $4.50, comprehensive Relmada Therapeutics, Inc. stock analysis, charts, news, and expert forecast. Real-time rlmd stock data and investment insights.
Loading chart...
Company Overview
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables, Florida.
Company Information
- CEO
- Sergio Traversa
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 17
Contact Information
- Website
- https://www.relmada.com
- Address
- 2222 Ponce de Leon Boulevard
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
Business Model & Strategy
Relmada Therapeutics, Inc. operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Sergio Traversa, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Relmada Therapeutics, Inc. competes in the Biotechnology within the broader Healthcare. With 149.5 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Select, Relmada Therapeutics, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Relmada Therapeutics, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Relmada Therapeutics, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Relmada Therapeutics, Inc.
- ⚠Investors should consider how Relmada Therapeutics, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
149.54M
P/E Ratio
-2.05
Beta
0.87
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 149.54M market capitalization
- Trading Volume: 1.48M shares traded today
- Price Range: 52-week range of $0.24 - $5.12
- Exchange: Listed on NASDAQ Global Select
Financial Metrics
Market Analysis for Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc. (RLMD) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 149.54M, the company represents a significant player in its market. The stock is currently trading at $4.50 with a positivedaily change of 5.48%.
The company's 17 employee base and presence on the NASDAQ Global Selectexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -2.05, beta of 0.87, and 52-week price range from $0.24 to $5.12when evaluating investment opportunities.
Why Invest in Relmada Therapeutics, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Select)
- • Experienced leadership under Sergio Traversa
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.